The first frontier
is already here.
Rampart™ DL Matrix is the in-market foundation: dehydrated, dual-layer human amniotic membrane for chronic and hard-to-heal wounds.
The product.
The surrounding record.
Donated placental tissue, recovered with informed consent and supplied in sheet formats. For use in diabetic foot ulcers, venous leg ulcers, arterial and mixed ulcers, pressure injuries, burns, and surgical and traumatic wounds.
| HCPCS | Q4347 |
|---|---|
| Tissue | Dehydrated, dual-layer human amniotic membrane |
| Format | Sheet |
| Sizes | 2 × 2, 2 × 3, 2 × 4, 4 × 4, 4 × 6 and 4 × 8 cm |
| Storage | Room temperature |
| Placement | No orientation requirement |
| Use | For qualified medical professionals only; not for over-the-counter sale |
| Product status | In market |
| Documentation | Measurement, coverage records and audit workflow |
The HCPCS code is listed for provider reference. Coverage is determined by the payer.
Diabetes weighs heaviest
in tribal communities.
Wound care is part of that picture.
Source: Indian Health Service, Division of Diabetes Treatment and Prevention, 2024 IHS Diabetes Care and Outcome Audit fact sheet (citing the CDC National Diabetes Statistics Report).
Follow the evidence trail.
Post-market validation
A study led by Principal Investigator David Burke, MD, MA, was submitted to CMS and all seven Medicare Administrative Contractors.
Receipt on the record
CHP reports government-to-government receipt confirmation. Receipt does not establish efficacy, coverage, approval or endorsement.
Read the milestone↗Get the full context
Request product information, clinical evidence, ordering details and the applicable coverage context directly from the team.
Ask a clinical question↗Standard care
comes first.
Medicare contractors’ coverage policies for skin substitutes on lower-extremity wounds call for more than four weeks of documented standard wound care before a skin substitute is considered. For venous leg ulcers, that care includes ongoing compression.
The record of that care matters: the platform’s coverage step checks the documented criteria before a claim is made.
Requirements differ by Medicare Administrative Contractor and change over time. This is general information, not a coverage determination. Sources: Novitas LCD L35041 · First Coast LCD L36377
Assessment
A full assessment of the wound and the person, including circulation and, for diabetic foot ulcers, blood-sugar management.
Debridement
Removing dead or infected tissue from the wound.
Pressure and swelling
Offloading pressure for diabetic foot ulcers, or compression for venous leg ulcers.
Infection control
Treating and preventing infection in and around the wound.
Moisture balance
Managing drainage and keeping the wound bed moist.
Smoking
Support to stop smoking.
Bring Rampart™ DL Matrix
to your facility.
Clinics, hospitals and tribal and federal health facilities can request product information, ordering details and the coverage documentation that applies to Rampart™ DL Matrix.
Request provider information↗Questions
patients ask.
General information, not medical advice. This website does not enroll patients. Ask your healthcare provider about your own care.
What is an amniotic membrane graft?
A thin sheet of tissue from donated placental membrane that a clinician places on a wound as a covering. Rampart™ DL Matrix is a dehydrated, dual-layer amniotic membrane.
How is it applied?
Your clinician cleans the wound, places the graft on the wound bed and covers it with a dressing. They will tell you how to care for the dressing.
Will I need more than one application?
It depends on the wound. Your clinician decides whether more applications are needed.
What if the graft comes off?
Contact your healthcare provider.
What should I watch for?
Contact your healthcare provider promptly if you notice more redness, swelling, pain or drainage at the wound.
Is it covered by insurance?
Coverage depends on your plan, your wound and your medical records. Your provider’s office can tell you what applies to you.
How do I know if it is right for me?
Your healthcare provider decides, usually after other wound care has been tried for several weeks.
What if the graft
could tell you more?
The pipeline explores sensing, protective and regenerative functions. None of these pipeline products is available today.
pH-Sense
A graft concept that visually signals wound status without electronics.
Anti-biofilm processing
Processing approaches aimed at the biofilm challenge in chronic wounds.
Flowable formats
Concepts for deep, tunneling and irregular wounds beyond sheet formats.
WoundGuide™
Benchtop work on colorimetric infection detection within the graft.
Capture & Active Shield
Research into repair-signal capture and biofilm detection and disruption.
Periwound monitoring
Battery-free, phone-read sensing concepts for the area beside the graft.
Bring the conversation to the clinic.
Request product and evidence information from the CHP team.
HEAL WELL. AGE WELL. LIVE LONGER.